AccSys

AccSys Technology, a subsidiary of Hitachi, specializes in the design and manufacture of ion linear accelerator (linac) systems for medical, industrial, and research applications. The company's core expertise lies in developing compact, high-performance radiofrequency quadrupole (RFQ) and drift-tube linac (DTL) systems. These systems are primarily utilized in proton therapy for cancer treatment, the production of radioisotopes for PET imaging, and neutron generation. By providing the foundational accelerator technology for advanced medical treatments, AccSys plays a critical role in the global oncology and diagnostic imaging infrastructure. Their products are known for their reliability and compact footprint, making advanced radiation therapy more accessible to clinical centers.